Stay updated on Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision label updated from v3.3.3 to v3.3.4. No substantive content or study details were changed.
    Difference
    0.1%
    Check dated 2026-01-14T01:41:15.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer updates show Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:50:05.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.3.2 deployed; no visible changes to Study Details page content or user-facing behavior.
    Difference
    0.1%
    Check dated 2025-12-01T17:38:57.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Publications are now described as auto-filled from PubMed, and the revision is labeled as v3.3.1. The previous wording about PubMed-sourced publications and the v3.2.0 revision reference have been removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:05.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Notice about government funding and operating status was removed from the page; this status notice previously informed users about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:52:23.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The two screenshots show the same study record with minor layout adjustments; there are no changes to core content like eligibility criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:17:28.000Z thumbnail image

Stay in the know with updates to Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.